BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29567775)

  • 1. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome.
    Criado I; Rodríguez-Caballero A; Gutiérrez ML; Pedreira CE; Alcoceba M; Nieto W; Teodosio C; Bárcena P; Romero A; Fernández-Navarro P; González M; Almeida J; Orfao A;
    Haematologica; 2018 Jul; 103(7):1198-1208. PubMed ID: 29567775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL.
    Fazi C; Scarfò L; Pecciarini L; Cottini F; Dagklis A; Janus A; Talarico A; Scielzo C; Sala C; Toniolo D; Caligaris-Cappio F; Ghia P
    Blood; 2011 Dec; 118(25):6618-25. PubMed ID: 21876118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones.
    Vander Meeren S; Heyrman B; Renmans W; Bakkus M; Maes B; De Raeve H; Schots R; Jochmans K
    Ann Hematol; 2018 Jul; 97(7):1219-1227. PubMed ID: 29492600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.
    Criado I; Muñoz-Criado S; Rodríguez-Caballero A; Nieto WG; Romero A; Fernández-Navarro P; Alcoceba M; Contreras T; González M; Orfao A; Almeida J;
    Haematologica; 2017 Jul; 102(7):1238-1246. PubMed ID: 28385786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia.
    Henriques A; Rodríguez-Caballero A; Nieto WG; Langerak AW; Criado I; Lécrevisse Q; González M; Pais ML; Paiva A; Almeida J; Orfao A
    PLoS One; 2013; 8(7):e67751. PubMed ID: 23844084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
    Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia.
    Villegas Gracia R; Franco Alzate C; Rendón Henao J; Torres Hernández JD; Jaramillo Arbelaez PE
    Colomb Med (Cali); 2016 Jun; 47(2):81-6. PubMed ID: 27546929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.
    Agathangelidis A; Ljungström V; Scarfò L; Fazi C; Gounari M; Pandzic T; Sutton LA; Stamatopoulos K; Tonon G; Rosenquist R; Ghia P
    Haematologica; 2018 May; 103(5):865-873. PubMed ID: 29449433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach.
    Nieto WG; Almeida J; Romero A; Teodosio C; López A; Henriques AF; Sánchez ML; Jara-Acevedo M; Rasillo A; González M; Fernández-Navarro P; Vega T; Orfao A;
    Blood; 2009 Jul; 114(1):33-7. PubMed ID: 19420353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
    Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
    Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
    Shanafelt TD; Kay NE; Jenkins G; Call TG; Zent CS; Jelinek DF; Morice WG; Boysen J; Zakko L; Schwager S; Slager SL; Hanson CA
    Blood; 2009 Apr; 113(18):4188-96. PubMed ID: 19015397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis.
    Parikh SA; Chaffee KG; Larson MC; Hampel PJ; Call TG; Ding W; Kenderian SS; Leis JF; Chanan-Khan AA; Conte MJ; Bowen D; Schwager SM; Slager SL; Hanson CA; Kay NE; Shanafelt TD
    Haematologica; 2018 Jun; 103(6):e237-e240. PubMed ID: 29419435
    [No Abstract]   [Full Text] [Related]  

  • 13. T/NK large granular lymphocyte leukemia and coexisting monoclonal B-cell lymphocytosis-like proliferations. An unrecognized and frequent association.
    Howard MT; Bejanyan N; Maciejewski JP; Hsi ED
    Am J Clin Pathol; 2010 Jun; 133(6):936-41. PubMed ID: 20472852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.
    Molica S; Mauro FR; Giannarelli D; Lauria F; Cortelezzi A; Brugiatelli M; Liso V; Cuneo A; Foà R
    Haematologica; 2011 Feb; 96(2):277-83. PubMed ID: 20971821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
    Scarfò L; Ghia P
    Semin Oncol; 2016 Apr; 43(2):201-8. PubMed ID: 27040697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics.
    Nieto WG; Teodosio C; López A; Rodríguez-Caballero A; Romero A; Bárcena P; Gutierrez ML; Langerak AW; Fernandez-Navarro P; Orfao A; Almeida J;
    Cytometry B Clin Cytom; 2010; 78 Suppl 1():S24-34. PubMed ID: 20839335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders.
    Henriques A; Rodríguez-Caballero A; Criado I; Langerak AW; Nieto WG; Lécrevisse Q; González M; Cortesão E; Paiva A; Almeida J; Orfao A
    Haematologica; 2014 May; 99(5):897-907. PubMed ID: 24488564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A.
    Furtado FM; Scheucher PS; Santana BA; Scatena NF; Calado RT; Rego EM; Matos DM; Falcão RP
    Braz J Med Biol Res; 2017 Apr; 50(5):e6019. PubMed ID: 28423121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?
    Angelillo P; Capasso A; Ghia P; Scarfò L
    Eur J Intern Med; 2018 Dec; 58():2-6. PubMed ID: 30268574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis.
    Amato D; Oscier DG; Davis Z; Mould S; Zheng J; Kolomietz E; Wang C
    Am J Clin Pathol; 2007 Aug; 128(2):333-8. PubMed ID: 17638670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.